Cargando…
Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis
Using the English Wikipedia network of more than 5 million articles we analyze interactions and interlinks between the 34 largest pharmaceutical companies, 195 world countries, 47 rare renal diseases and 37 types of cancer. The recently developed algorithm using a reduced Google matrix (REGOMAX) all...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892506/ https://www.ncbi.nlm.nih.gov/pubmed/31800621 http://dx.doi.org/10.1371/journal.pone.0225500 |
_version_ | 1783476041486958592 |
---|---|
author | Rollin, Guillaume Lages, José Serebriyskaya, Tatiana S. Shepelyansky, Dima L. |
author_facet | Rollin, Guillaume Lages, José Serebriyskaya, Tatiana S. Shepelyansky, Dima L. |
author_sort | Rollin, Guillaume |
collection | PubMed |
description | Using the English Wikipedia network of more than 5 million articles we analyze interactions and interlinks between the 34 largest pharmaceutical companies, 195 world countries, 47 rare renal diseases and 37 types of cancer. The recently developed algorithm using a reduced Google matrix (REGOMAX) allows us to take account both of direct Markov transitions between these articles and also of indirect transitions generated by the pathways between them via the global Wikipedia network. This approach therefore provides a compact description of interactions between these articles that allows us to determine the friendship networks between them, as well as the PageRank sensitivity of countries to pharmaceutical companies and rare renal diseases. We also show that the top pharmaceutical companies in terms of their Wikipedia PageRank are not those with the highest market capitalization. |
format | Online Article Text |
id | pubmed-6892506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-68925062019-12-14 Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis Rollin, Guillaume Lages, José Serebriyskaya, Tatiana S. Shepelyansky, Dima L. PLoS One Research Article Using the English Wikipedia network of more than 5 million articles we analyze interactions and interlinks between the 34 largest pharmaceutical companies, 195 world countries, 47 rare renal diseases and 37 types of cancer. The recently developed algorithm using a reduced Google matrix (REGOMAX) allows us to take account both of direct Markov transitions between these articles and also of indirect transitions generated by the pathways between them via the global Wikipedia network. This approach therefore provides a compact description of interactions between these articles that allows us to determine the friendship networks between them, as well as the PageRank sensitivity of countries to pharmaceutical companies and rare renal diseases. We also show that the top pharmaceutical companies in terms of their Wikipedia PageRank are not those with the highest market capitalization. Public Library of Science 2019-12-04 /pmc/articles/PMC6892506/ /pubmed/31800621 http://dx.doi.org/10.1371/journal.pone.0225500 Text en © 2019 Rollin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rollin, Guillaume Lages, José Serebriyskaya, Tatiana S. Shepelyansky, Dima L. Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis |
title | Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis |
title_full | Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis |
title_fullStr | Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis |
title_full_unstemmed | Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis |
title_short | Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis |
title_sort | interactions of pharmaceutical companies with world countries, cancers and rare diseases from wikipedia network analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892506/ https://www.ncbi.nlm.nih.gov/pubmed/31800621 http://dx.doi.org/10.1371/journal.pone.0225500 |
work_keys_str_mv | AT rollinguillaume interactionsofpharmaceuticalcompanieswithworldcountriescancersandrarediseasesfromwikipedianetworkanalysis AT lagesjose interactionsofpharmaceuticalcompanieswithworldcountriescancersandrarediseasesfromwikipedianetworkanalysis AT serebriyskayatatianas interactionsofpharmaceuticalcompanieswithworldcountriescancersandrarediseasesfromwikipedianetworkanalysis AT shepelyanskydimal interactionsofpharmaceuticalcompanieswithworldcountriescancersandrarediseasesfromwikipedianetworkanalysis |